The escalation in the global prevalence of obesity is a pivotal factor contributing to the development of cellulite. This connection arises from the augmentation of fat volume confined within irregularly sized fat lobules. In individuals grappling with obesity, fat cells, scientifically referred to as adipocytes, undergo an expansion, resulting in bulging due to the accumulation of fat. Notably, obesity stands as the primary catalyst for the manifestation of cellulite, as it induces alterations in the adipose tissue structure. The World Health Organization (WHO) has documented a threefold increase in the population affected by obesity since 1975. Alarming statistics from 2020 revealed that a staggering 39 million children under the age of five were afflicted by obesity, emphasizing the global nature of this health concern.
Data from the Centers for Disease Control and Prevention (CDC) in 2018 underscore the magnitude of obesity as a prevalent issue in the United States. The findings reveal that 40.0% of adults aged 20 to 39, 44.8% of adults aged 40 to 59, and 42.8% of adults aged 60 and older were identified as obese. The classification of adults with a body mass index (BMI) equal to or exceeding 25 denotes an overweight medical condition, while a BMI equal to or surpassing 30 signifies obesity. Consequently, the surge in the number of obesity cases worldwide serves as a driving force behind the burgeoning cellulite treatment market.
Moreover, the demographic encompassing individuals aged 18 to 25 emerges as particularly susceptible to cellulite deposition due to dietary habits characterized by the consumption of energy-dense foods rich in fats and sugars. This younger population segment, driven by lifestyle choices, is predisposed to cellulite development. Additionally, individuals aged 25 to 35, a cohort often focused on career advancement, exhibit tendencies that contribute to cellulite formation. The adoption of unhealthy dietary patterns, prolonged periods of sedentary work, and minimal engagement in physical activities collectively result in the accumulation of fat and tissues in the lower regions of the body. This lifestyle-driven propensity for cellulite formation not only necessitates cellulite treatment but also projects an anticipated surge in market demand during the forecast period.
In essence, the intertwining factors of escalating global obesity rates, particularly among the younger and career-focused demographics, underscore the critical role played by lifestyle choices in cellulite development. The consequential demand for effective cellulite treatment solutions is poised to fuel market growth, emphasizing the imperative for innovative approaches to address this prevalent cosmetic concern. As the cellulite treatment market responds to the evolving landscape of lifestyle-related health issues, its trajectory is likely to witness sustained expansion in the foreseeable future.
Report Attribute/Metric | Details |
---|---|
Market Opportunities | Growing medical tourism industry |
Market Dynamics | Increasing number of obese cases across the globe Rising demand for aesthetic and cosmetic procedures |
Cellulite Treatment Market Size was valued at USD 0.5 billion in 2022. The cellulite treatment market industry is projected to grow from USD 0.554 billion in 2023 to USD 1.268 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.90% during the forecast period (2023 - 2032). Major market drivers of its expansion include an increase in the number of cosmetic hospitals, rising healthcare costs, and rising public awareness of cutting-edge cellulite treatments.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The amount of fat that is trapped within different-sized fat lobules increases as a result of obesity, which is what produces cellulite. Obesity is the main contributing factor to cellulite in obese individuals as fat cells (adipocytes) enlarge and protrude. Since 1975, there has been a threefold increase in obesity, according to the WHO. The industry for treating cellulite is growing as a result of the rising prevalence of obesity in the world. Due to their excessive consumption of meals that are high in calories, fat, and sugar, the young population between the ages of 18 and 25 is also prone to the deposition of cellulite. Similarly, people between the ages of 25 and 35 who are motivated by career growth eat unhealthy meals, sit for long periods at work, and exercise little, which leads to the deposition of fat and tissue in the lower body area. This way of living drives the need for cellulite treatments for tissue and fat depositions, and it is anticipated that this will drive the market CAGR during the projection period.
Cosmetic procedures include laser therapy, non-surgical fat removal, carboxytherapy, chemical peels, radiofrequency, subcision, vacuum-assisted precise tissue release, laser-assisted liposuction, and ultrasound are becoming more popular in developing economies. This is a result of the growing acceptance of cosmetic procedures and disposable income. Improved healthcare infrastructure in developing countries also helps the sector grow. Additionally, it is anticipated that the growing number of cosmetic surgeons in developing countries would generate significant prospective prospects. Furthermore, the rising popularity of minimally invasive cosmetic procedures presents opportunities for market growth. Around 193,237 complete surgical procedures and 232,584 complete non-surgical treatments were performed in Argentina in 2019.
Additionally, the introduction of new products is anticipated to promote market expansion. For instance, Merz Pharma debuted Cellfina in 2016, a cellulite treatment lasting at least three years and improving its appearance. Over 93% of treated patients were satisfied with the results of their therapy, and this strategy has the potential to benefit over 78% of American women. As a result, these cutting-edge solutions are anticipated to speed up market growth. Minimally invasive techniques are replacing invasive ones. For instance, according to the American Society of Plastic Surgeons, 473,316 of the 15.9 million cosmetic minimally invasive treatments conducted in 2018 involved non-invasive fat removal. Thus, driving the cellulite treatment market revenue.
The cellulite treatment market segmentation, based on treatment procedure includes Non-Invasive, Minimally-Invasive and Topical Treatment. The non-invasive segment dominated the market. This can be due to both the procedure's great availability and the ongoing R&D efforts. In terms of market share, the topical sector came second to the non-invasive segment. Topical cellulite treatment solutions can be applied without the help of a medical professional and at the user's convenience at home, which is boosting market growth.
The cellulite treatment market segmentation, based on cellulite type, includes Hard Cellulite, Soft Cellulite and Edematous Cellulite. The soft cellulite category generated the most income. This is explained by the high prevalence of obesity brought on by poor dietary and lifestyle choices. The buttocks, abdomen, thighs, and arms are the main body parts where soft cellulite can be detected. Some of the most popular treatments for soft cellulite include increasing muscular tone through exercise, sustained weight loss, proper protein intake, radio-frequency treatments, and topical applications.
Figure 1: Cellulite Treatment Market, by Cellulite Type, 2022 & 2032 (USD billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The cellulite treatment market segmentation, based on end use, includes Hospitals, Ambulatory Surgical Centers, and Specialized Dermatology Clinics. The specialized dermatology clinics category generated the most income due to the ease with which patients can obtain highly qualified staff and accredited professionals at these clinics. Patients are becoming more and more interested in minimally invasive cosmetic procedures.
Cellulite Treatment Regional Insights
By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American cellulite treatment market area will dominate this market because there are so many highly qualified people in the area, so many cutting-edge technologies, and so many encouraging government programmes. Furthermore, the adoption and accessibility of cutting-edge treatment methods, like laser procedures, is fostering market expansion in this area. The industry's expansion in North America is also being fueled by a growing awareness of aesthetic appeal and external appearance.
Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: CELLULITE TREATMENT MARKET SHARE BY REGION 2022 (%)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe cellulite treatment Market is expected to grow at the fastest CAGR from 2023 to 2032. This is brought on by the expanding use of non-invasive technology, the commercial release of new goods, the adoption of unhealthy lifestyles and excessive consumption of fatty foods, as well as the increased demand for cosmetic solutions for the treatment of cellulite. The increased usage of topical therapies and medical tourism are two additional variables affecting the development of the cellulite treatment industry in Europe. Further, the German cellulite treatment market held the largest market share, and the UK cellulite treatment market was the fastest growing market in the European region
Asia Pacific cellulite treatment market accounts for the second-largest market share. The lower cost of care, rising disposable income, and rising rates of obesity in this area can all be considered contributing factors. As emerging nations, the bulk of the nations in this region are quickly embracing modern technology. Due to the high rate of medical tourism in this area, industry growth is expected to be accelerated. Moreover, China’s cellulite treatment market held the largest market share, and the Indian cellulite treatment market was the fastest growing market in the Asia-Pacific region.
Cellulite Treatment Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the cellulite treatment market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, cellulite treatment industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the cellulite treatment industry to benefit clients and increase the market sector. In recent years, the cellulite treatment industry has offered some of the most significant advantages to medicine. Major players in the cellulite treatment market are attempting to increase market demand by investing in research and development operations are Hologic, Nubway Co.Ltd. (China), Merz Pharma GmbH & Co. KGaA (Germany), Zimmer Aesthetics (Germany), Cymedics (Germany), Cynosure, Inceler Medikal Co. Ltd (Turkey), Candela Medical (US), Cutera, and Beijing Sincoheren S & T Development Co.Ltd.
Cutera Inc. (Cutera) produces, develops, distributes, and supports medical and cosmetic devices. The business offers laser and energy-based aesthetics systems, including xeo, secret RF, truSculpt iD, and truSculpt 3D, as well as the Excel HR, Excel V, Juliet, and truSculpt technologies. Its products are intended to treat hair removal on the face and body as well as skin rejuvenation. The Enlighten gadget from Cutera is used for benign pigmented lesions therapy and tattoo removal. In April 2023, CUTERA, INC., a provider of customer payment and financing solutions, announced an exclusive partnership to expand patient financing alternatives for dermatology procedures throughout the US.
The energy-based beauty and medical treatment systems created by Cynosure are leaders, innovators, developers, and best-in-class innovators. For hair removal, skin rejuvenation, scar reduction, gynecological health, body contouring, and other leading therapy applications, Cynosure develops and manufactures a wide range of products. Its cutting-edge goods are utilised by professionals, medical professionals, and owners of aesthetic businesses all around the world to help them improve their services and offer patients the most recent treatments. In terms of advanced levels of solid state liquid and semiconductor technologies, Cynosure is still a market leader in energy-based systems. In April 2022, Cynosure announced a deal to buy the MyEllevate Surgical Suture System at The Aesthetic Society's "The Aesthetic Meeting 2022," expanding the business's selection of minimally invasive facial rejuvenation procedures.
Key Companies in the cellulite treatment market include
Hologic
Nubway Co.Ltd. (China)
Merz Pharma GmbH & Co. KGaA (Germany)
Zimmer Aesthetics (Germany)
Cymedics (Germany)
Cynosure
Inceler Medikal Co. Ltd (Turkey)
Candela Medical (US)
Cutera
Beijing Sincoheren S & T Development Co.Ltd
Cellulite Treatment Industry Developments
January 2023: With SofwaveTM, a procedure permitted by the American Food and Drug Administration (FDA) to lessen the appearance of cellulite, the dermal layer can be targeted and thickened. This cutting-edge ultrasound delivery technique, called Synchronous Ultrasound Parallel Beam Technology (SUPERBTM), is utilised to increase the body's production of collagen.
May 2022: AvéliTM, a game-changing revolutionary cellulite device, has been introduced by Revelle Aesthetics, Inc., a VC-backed Silicon Valley MedTech business dedicated to inventing precision solutions that tackle the cause of women's most annoying aesthetic challenges.
Non-Invasive
Minimally-Invasive
Topical Treatment
Hard Cellulite
Soft Cellulite
Edematous Cellulite
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
Cellulite Treatment Regional Outlook (USD Billion, 2018-2032)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Australia
Rest of Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)